![]() Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies | |
Founding Date | Founding Date 1998 | Founding Date 2006 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US |
Employees | Employees 110 | Employees 91 |
Financial | ||
Revenue (est.) | Revenue (est.) $173.8m (FY, 2018) | Revenue (est.) £48.7m (FY, 2025) |
Cost of goods | Cost of goods $59.4m (FY, 2018) | Cost of goods £11.1m (FY, 2025) |
Gross profit | Gross profit $114.4m (FY, 2018) | Gross profit £38.2m (FY, 2025) |
Net income | Net income ($147.7m) (FY, 2018) | Net income £7m (FY, 2025) |
NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies
View company